Literature DB >> 1376300

Studies of clonal cell lines developed from primary breast cancers indicate that the ability to undergo morphogenesis in vitro is lost early in malignancy.

M Shearer1, J Bartkova, J Bartek, F Berdichevsky, D Barnes, R Millis, J Taylor-Papadimitriou.   

Abstract

In an attempt to obtain cell lines from the different components found in primary breast cancers, we used a low-calcium medium to culture epithelial cells of mixed phenotype and a recombinant T antigen containing retrovirus to immortalize cells found in these cultures. In each case, the histology of the sample used for culture was examined in detail and the best growth was obtained from samples associated with a substantial in situ or benign component and from lobular rather than ductal carcinomas. Clonal cell lines were developed from each of 4 tumours: 1 infiltrating ductal (tumour number 2), 2 infiltrating lobular (tumours 3 and 5) and 1 mucoid (tumour 6). To try to identify the phenotype and origin of the cell lines, immunohistochemical markers, histological analysis of tissue sections and behavioural markers were used. All the cell lines expressed mainly luminal epithelial cell markers, but the basal epithelial keratin, keratin 14, was also expressed homogeneously or heterogeneously. Growth in agar was seen with some but not all cell lines derived from only 1 tumour (tumour 5) and tumour development in nude mice was observed (with low efficiency) with cell lines from only 1 tumour (tumour 6). The data suggest that the cell lines obtained from the infiltrating ductal carcinoma (tumour 2) developed from cells cultured from the associated benign component, while the cell lines from tumours 3, 5 and 6 may each have developed from a cell in an early stage of malignancy. When tested for their ability to undergo morphogenesis on extracellular matrix components, cell lines from tumour 2 made well-developed ductal-alveolar-like structures, while those from the other tumours did not.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376300     DOI: 10.1002/ijc.2910510417

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay.

Authors:  V M Weaver; A H Fischer; O W Peterson; M J Bissell
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

Review 3.  Cell adhesion molecules in the normal and cancerous mammary gland.

Authors:  D Alford; J Taylor-Papadimitriou
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 4.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

5.  Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures.

Authors:  H M Ogmundsdóttir; I Pétursdóttir; I Gudmundsdóttir; L Amundadóttir; L Rønnov-Jessen; O W Petersen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

6.  A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.

Authors:  C Whitehouse; J Burchell; S Gschmeissner; I Brockhausen; K O Lloyd; J Taylor-Papadimitriou
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

7.  Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.

Authors:  Elena Odintsova; Guillaume van Niel; Hélène Conjeaud; Graça Raposo; Ryo Iwamoto; Eisuke Mekada; Fedor Berditchevski
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

8.  Short-term primary culture of epithelial cells derived from human breast tumours.

Authors:  V Speirs; A R Green; D S Walton; M J Kerin; J N Fox; P J Carleton; S B Desai; S L Atkin
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

9.  Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.

Authors:  F Basolo; L Fiore; S Calvo; V Falcone; P G Conaldi; G Fontanini; A M Caligo; G Merlo; Y Gluzman; A Toniolo
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

10.  Characterization of organoid cultured human breast cancer.

Authors:  Nadine Goldhammer; Jiyoung Kim; Vera Timmermans-Wielenga; Ole William Petersen
Journal:  Breast Cancer Res       Date:  2019-12-11       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.